BlackRock reports 5,977,264 AORT shares, equal to 12.7% ownership
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
BlackRock, Inc. filed Amendment No. 5 to Schedule 13G reporting beneficial ownership of 5,977,264 shares of Artivion, Inc. (AORT) common stock, representing 12.7% of the class as of 09/30/2025.
BlackRock reports sole voting power over 5,912,256 shares and sole dispositive power over 5,977,264 shares, with no shared voting or dispositive power. The filing states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control. The interest of iShares Core S&P Small-Cap ETF in Artivion’s common stock is noted as more than five percent of outstanding shares.
Positive
- None.
Negative
- None.
FAQ
What stake did BlackRock report in Artivion (AORT)?
BlackRock reported beneficial ownership of 5,977,264 shares, or 12.7% of Artivion’s common stock as of 09/30/2025.
What is the date tied to this ownership report for AORT?
The reported ownership is tied to the 09/30/2025 event date.
Did BlackRock indicate any intent to influence control at Artivion?
No. The filing certifies the securities were acquired and held in the ordinary course of business, not to change or influence control.
Which BlackRock-affiliated fund holds over 5% of AORT?
The filing notes that iShares Core S&P Small-Cap ETF has an interest of more than five percent of Artivion’s outstanding common stock.